Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21870281 | 1.00 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL15852051 | 0.91 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL15852054 | 0.90 | AHR (0.32) | — | |
| SCHEMBL24767389 | 0.90 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL21870467 | 0.89 | CA12 (0.32) | — | |
| SCHEMBL21870051 | 0.89 | MAPT (0.30) | — | |
| SCHEMBL15852075 | 0.88 | ALOX5 (0.34) | ALOX5 | |
| SCHEMBL22818023 | 0.88 | ALOX5 (0.36) | ALOX5 | |
| SCHEMBL21870291 | 0.88 | PLA2G2A (0.32) | — | |
| SCHEMBL22817968 | 0.88 | ALOX5 (0.36) | ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230011996-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-12 | — | — | US | disclosed |
| US-11552252-B1 | — | — | 2023-01-10 | — | — | US | disclosed |
| US-20220029099-A1 | NOVEL COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-01-27 | — | — | US | disclosed |
| US-20200111962-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230011996-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, ESR1 | ALOX5 4494/4885 |
| US-20220029099-A1 | NOVEL COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME | RER1, RIF1, RPS19 | ALOX5 3822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.